dicloxacillin has been researched along with cefazolin in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (41.18) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Calderon, E; Howard, JB; Larrondo, J; McCraken, GH; Tetzlaff, TR | 1 |
Inoue, M; Mitsuhashi, S; Okubo, T | 1 |
Miller, SJ | 1 |
Bartlett, RC; Marcon, MJ | 1 |
Bandelloni, A; Bertino, E; Cavo, L; Fabris, C; Garzena, E; Licata, D | 1 |
Carney, DN; Fossieck, BE; Parker, RH | 1 |
Battaglino, G; Praderio, R; Zamboni, G | 1 |
Burns, JL; Leighty, SM; Myall, RW; Spach, DH | 1 |
Azeredo, J; Cerca, N; Henriques, M; Oliveira, R | 1 |
Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H | 1 |
2 review(s) available for dicloxacillin and cefazolin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Septic arthritis of the temporomandibular joint: review of the literature and report of two cases in children.
Topics: Arthritis, Infectious; Cefazolin; Child; Clindamycin; Dicloxacillin; Drainage; Female; Humans; Male; Nafcillin; Staphylococcal Infections; Temporomandibular Joint Disorders | 1993 |
2 trial(s) available for dicloxacillin and cefazolin
Article | Year |
---|---|
[Apropos of infection prevention in the neonatal period. Clinico-statistical studies on the use of some antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Clinical Trials as Topic; Dicloxacillin; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases | 1981 |
Staphylococcal bacteremia in cancer patients: intravenous and oral antimicrobial therapy.
Topics: Administration, Oral; Cefazolin; Cephalexin; Cephalosporins; Cephalothin; Clinical Trials as Topic; Dicloxacillin; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Nafcillin; Neoplasms; Sepsis; Staphylococcal Infections | 1982 |
13 other study(ies) available for dicloxacillin and cefazolin
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antibiotic concentrations in pus and bone of children with osteomyelitis.
Topics: Adolescent; Anti-Bacterial Agents; Bone and Bones; Cefazolin; Cephaloridine; Child; Child, Preschool; Dicloxacillin; Female; Humans; Male; Methicillin; Osteomyelitis; Protein Binding; Staphylococcus aureus; Suppuration | 1978 |
Antibacterial activity of combinations of cefazolin and semisynthetic penicillins.
Topics: Cefazolin; Cephalosporins; Cloxacillin; Dicloxacillin; Dose-Response Relationship, Drug; Drug Synergism; Escherichia; Penicillin Resistance; Proteus; Regression Analysis | 1975 |
The diagnosis and treatment of infections of the pedal integument.
Topics: Adult; Bone Screws; Cefazolin; Dicloxacillin; Foot Dermatoses; Humans; Male; Nails, Ingrown; Osteomyelitis; Staphylococcal Skin Infections; Staphylococcus aureus; Tetracycline; Toe Joint; Toes | 1986 |
Laboratory evaluation of the serum dilution test in serious staphylococcal infection.
Topics: Anti-Bacterial Agents; Biological Availability; Cefazolin; Cephalexin; Culture Media; Dicloxacillin; Evaluation Studies as Topic; Humans; Oxacillin; Penicillin Resistance; Protein Binding; Serologic Tests; Staphylococcal Infections; Staphylococcus aureus | 1983 |
[Clinical results of the use of the antibiotic cefazolin-dicloxacillin combination in respiratory tract infections].
Topics: Bronchitis; Bronchopneumonia; Cefazolin; Child; Child, Preschool; Dicloxacillin; Drug Combinations; Female; Humans; Infant; Male; Pharyngitis; Pleurisy; Respiratory Tract Infections; Tonsillitis | 1982 |
Influence of sub-inhibitory concentrations of antimicrobial agents on biofilm formation in indwelling medical devices.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida; Cefazolin; Dicloxacillin; Fluconazole; Humans; Staphylococcus epidermidis; Vancomycin | 2005 |
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |